"It is often not possible to use PSA changes to identify worsening or improvements in bone metastatic prostate cancer. BONENAVI - EXINIbone(BSI) - makes it possible to calculate BSI automatically from bone scans. BSI has shown to better correlate with the disease progression of bone metastases and to be more useful in treatment assessment than methods used today.
I also use the BSI values from
the BONENAVI reports to discuss disease improvements and changes with
our patients. The BSI is easy for them to understand and our patients
find it very useful."